Back to search

Response, toxicity, failure patterns, and survival in five radiation therapy oncology group (RTOG) trials of sequential and/or concurrent chemotherapy and radiotherapy for locally advanced non–small-cell carcinoma of the lung

Data up to Jan 2025

Published1998
Citations225
References21

Total Citations Per Year

Abstract

References (21)

Effects of Concomitant Cisplatin and Radiotherapy on Inoperable Non-Small-Cell Lung Cancer

1992 • 1,287 citations

A Randomized Trial of Induction Chemotherapy plus High-Dose Radiation versus Radiation Alone in Stage III Non-Small-Cell Lung Cancer

1990 • 1,163 citations

Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588: Preliminary Results of a Phase III Trial in Regionally Advanced, Unresectable Non-Small-Cell Lung Cancer

1995 • 721 citations

Long-term observations of the patterns of failure in patients with unresectable non-oat cell carcinoma of the lung treated with definitive radiotherapy report by the radiation therapy oncology group

1987 • 607 citations

A randomized phase I/II trial of hyperfractionated radiation therapy with total doses of 60.0 Gy to 79.2 Gy: possible survival benefit with greater than or equal to 69.6 Gy in favorable patients with Radiation Therapy Oncology Group stage III non-small-cell lung carcinoma: report of Radiation Therapy Oncology Group 83-11.

1990 • 474 citations

Inoperable non-small cell lung cancer: Radiation with or without chemotherapy

1988 • 205 citations

Thoracic Radiation Therapy Alone Compared with Combined Chemoradiotherapy for Locally Unresectable Non-Small Cell Lung Cancer

1991 • 190 citations

Concurrent chemoradiation therapy with oral etoposide and cisplatin for locally advanced inoperable non-small-cell lung cancer: radiation therapy oncology group protocol 91-06.

1996 • 175 citations

Radiotherapy alone versus combined chemotherapy and radiotherapy in unresectable non-small cell lung carcinoma

1994 • 146 citations

A randomized clinical trial comparing radiation therapy v radiation therapy plus cis-dichlorodiammine platinum (II) in the treatment of locally advanced non-small cell lung cancer.

1988 • 126 citations

Concurrent hyperfractionated irradiation and chemotherapy for unresectable nonsmall cell lung cancer. Results of radiation therapy oncology group 90-15

1995 • 87 citations

Phase II Trial of Combination Chemotherapy and Irradiation in Non-Small-Cell Lung Cancer, Radiation Therapy Oncology Group 88–04

1992 • 48 citations

Radiotherapy alone versus chemotherapy with ifosfamide/vindesine followed by radiotherapy in unresectable locally advanced non-small cell lung cancer.

1994 • 42 citations

Results of combination chemotherapy and thoracic radiation therapy for unresectable non-small cell carcinoma of the lung

1989 • 41 citations

The treatment of non-small cell lung cancer: Current perspectives and controversies, future directions

1995 • 34 citations

Report of phase ii trial of concurrent chemoradiotherapy with radical thoracic irradiation (60 gy), infusional fluorouracil, bolus cisplatin and etoposide for clinical stage IIIB and bulky iiia non-small cell lung cancer

1993 • 30 citations

Hyperfractionated radiation therapy with and without concurrent chemotherapy for advanced non–small cell lung cancer

1993 • 26 citations

Effect of radiologic stage III substage on nonsurgical therapy of non-small cell lung cancer

1993 • 25 citations

Radiation and simultaneous cisplatin in non-small cell lung cancer

1993 • 6 citations

Treatment of non-small cell lung cancer

2001 • 4 citations

Alternated approach with local irradiation and combination chemotherapy including cisplatin or carboplatin plus epirubicin and etoposide in intermediate stage non-small cell lung cancer

1995 • 1 citations

Cited By (0)

Loading...
Response, toxicity, failure patterns, and survival in five radiation therapy oncology… (1998) – International Journal of Radiation Oncology*Biology*Physics | Metascience Observatory Explorer